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Abstract
Background: The shear-stress induced transcription factor KLF2 has been shown to induce an atheroprotective phenotype
in endothelial cells (EC) that are exposed to prolonged laminar shear. In this study we characterized the effect of the shear
stress-induced transcription factor KLF2 on regulation and composition of Weibel-Palade bodies (WPBs) using peripheral
blood derived ECs.
Methodology and Principal Findings: Lentiviral expression of KLF2 resulted in a 4.5 fold increase in the number of WPBs
per cell when compared to mock-transduced endothelial cells. Unexpectedly, the average length of WPBs was significantly
reduced: in mock-transduced endothelial cells WPBs had an average length of 1.7 mm versus 1.3 mm in KLF2 expressing
cells. Expression of KLF2 abolished the perinuclear clustering of WPBs observed following stimulation with cAMP-raising
agonists such as epinephrine. Immunocytochemistry revealed that WPBs of KLF2 expressing ECs were positive for IL-6 and
IL-8 (after their upregulation with IL-1b) but lacked angiopoietin-2 (Ang2), a regular component of WPBs. Stimulus-induced
secretion of Ang2 in KLF2 expressing ECs was greatly reduced and IL-8 secretion was significantly lower.
Conclusions and Significance: These data suggest that KLF2 expression leads to a change in size and composition of the
regulated secretory compartment of endothelial cells and alters its response to physiological stimuli.
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Introduction
Endothelial cells (ECs) are subjected to blood-flow generated
laminar shear stress. The laminar flow in blood vessels is pulsatile
and can reach shear stress levels of 10 to 70 dyne/cm2 [1,2]. High
shear stress induces an atheroprotective endothelial phenotype
while absence of shear stress, as occurs near bends and at
bifurcations, leads to endothelial dysfunction, characterized by a
reduction in barrier function and upregulation of pro-inflamma-
tory gene expression [2,3,4]. These sites of disturbed blood flow
are more prone to atherosclerotic lesion development [2,5]. It is
well-established that hemodynamic forces have a considerable
impact on vascular ECs [2]. One of the transcription factors that
are induced by hemodynamic forces is Kru¨ppel-like factor 2
(LKLF, KLF2), which was found to be absent from atheroprone
vascular regions and may be considered atheroprotective [6].
Increased expression of KLF2 is also induced by 3-hydroxy-3-
methyl-glutaryl-CoA reductase inhibitors (statins) while inflamma-
tory cytokines are found to reduce transcription of KLF2 [7,8].
Ectopic expression of KLF2 induces both functional and
morphological changes in endothelial cells which mimic the effects
of shear stress. KLF2 was shown to affect the expression of
vascular tone regulating genes which enables the establishment of
a functionally quiescent endothelium [3]. ECs expressing KLF2
display anti-inflammatory, anti-thrombotic, anti-migratory, anti-
fibrotic and anti-oxidant properties [9,10].
A number of thrombotic and inflammatory mediators originate
from EC-specific, elongated secretory organelles called Weibel-
Palade bodies (WPBs). WPBs function as storage vesicle for von
Willebrand Factor (VWF), a multimeric glycoprotein which plays
a crucial role in platelet plug formation [11,12,13]. In addition,
these organelles also contain other bioactive compounds including
P-selectin [14,15], lamp3 [16], Ang2 [17], IL-8 [18,19], eotaxin-3
[20], osteoprotegerin-1 [21] and endothelin-1 [22], the release of
which enables the endothelium to actively participate in inflam-
matory responses, angiogenesis and regulation of vascular tone.
Upon stimulation of the ECs with agonists that raise Ca2+ or
cAMP levels, for example thrombin and epinephrine respectively,
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WPBs fuse with the plasma membrane resulting in release of their
contents in the circulation and exposure of P-selectin on the
plasma membrane. However, a subset of WPBs is able to escape
regulated exocytosis in response to cAMP-raising agonists and
form a perinuclear cluster at the microtubule organizing center
(MTOC) [23]. The minus-end directed transport of WPBs along
the microtubules to the MTOC is mediated by the dynein/
dynactin complex and protein kinase A (PKA) [24].
We have recently shown that expression of KLF2 modulates the
thrombin-induced release of WPBs whereas the epinephrine-
induced release of these organelles was not affected [3]. In this
work we have further characterized the atheroprotective pheno-
type induced by KLF2 with regard to the secretory pathway of
ECs. We show that lentiviral expression of KLF2 leads to an
altered morphology and composition of WPBs and results in
impaired regulated secretion of Ang2 and (to a lesser extent) IL-8.
Strikingly, we found that KLF2 expressing cells no longer display
perinuclear clustering of WPBs after stimulation with cAMP-
mediated agonists. Our data indicate that the atheroprotective
phenotype of KLF2 expressing ECs extends to their regulated
secretory pathway and markedly alters the composition and
regulation of their secretory response.
Materials and Methods
Reagents and Antibodies
EGM-20 medium, epinephrine, thrombin, phorbol 12-myris-
tate 13-acetate (PMA), forskolin and 3-isobutyl-1-methylxanthine
(IBMX) were from Sigma Aldrich (Steinheim, Germany). Mouse
monoclonal anti-a-tubulin antibody and mouse IgG1 anti c-
tubulin were also from Sigma. Rabbit anti-b-catenin (sc-7199)
antibody was from Santa Cruz Biotechnology (Santa Cruz, CA).
Mouse monoclonal anti-human angiopoietin-2, mouse monoclo-
nal anti-IL-6 and mouse monoclonal anti-OPG antibodies were
from R&D (Minneapolis, MN). Rabbit polyclonal anti-P-selectin
antibody was obtained from BD Biosciences, (San Jose, USA). The
rabbit polyclonal anti-KLF2 antibody has been described previ-
ously [3]. The sheep anti-mouse HRP antibody and the donkey
anti-rabbit HRP antibody were from GE Healthcare (Hoevelaken,
the Netherlands). Alexa 405-, 488-, 568-, 633-conjugated second-
ary antibodies were from Molecular Probes (Breda, the Nether-
lands). IL-1b was from Strathman Biotech (Hannover, Germany).
Chemiluminescence blotting substrates were from Roche Diag-
nostics (Mannheim, Germany). The duoset Ang2 ELISA kit was
from R&D. PeliKine human IL-8 and IL-6 ELISA kits were
purchased from Sanquin (Amsterdam, the Netherlands). Mouse
monoclonal anti-IL-8 was frome Sanquin (Amsterdam, the
Netherlands). The serum-free (SF) medium contained RPMI and
M199 (in a 1:1 ratio) supplemented with 0.3 g/L L-glutamine
(Sigma) and 1% human serum albumin (Sanquin, Amsterdam, the
Netherlands) and penicillin and streptomycin (BD Biosciences). All
chemicals used were of analytical grade.
Cell Culture and Agonist Stimulation
Blood outgrowth endothelial cells (BOECs) were isolated as
previously described [25] from 50 ml of venous blood that was
drawn from healthy anonymous volunteers, with written permis-
sion, in accordance with Dutch regulations and approval from
Sanquin Ethical Advisory Board. Mock and KLF2 lentivirus were
prepared as described previously [26]. Passage 6 BOECs were
transduced by a single exposure to KLF2 or mock lentivirus in the
presence of 8 mg/ml polybrene and centrifuged for 90 minutes at
1200 rpm and 37uC. After a total incubation time of 4 hours at
37uC, the medium was refreshed. Transduced cells were cultured
using the standard cell culture protocols for BOECs. For the
stimulation with epinephrine and forskolin, BOECs were grown in
12-wells plates to confluency. Before stimulation, cells were
washed two times with serum-free (SF) medium and pre-incubated
in SF medium for 1 hour at 37uC. To measure IL-6 and IL-8
release, cells were stimulated with 10 ng/ml IL-1b in EGM-20
medium for 24 hours [18] and pre-incubated with serum-free
medium without IL-1b 6 hours prior to stimulation [27].
Stimulation was performed by replacing the pre-incubation
medium with SF medium containing 10 mM epinephrine and
100 mM IBMX, 10 mM forskolin and 100 mM IBMX or 50 ng/ml
PMA and further incubation for 1 hour at 37uC.
Western Blotting and Immunofluorescence
Western blot was performed essentially as described previously
[28]. Multimeric composition of VWF was analysed as previously
decribed [29]. For immunofluorescence KLF2- and mock-
transfected BOECs were grown on collagen-coated glass cover-
slips, fixed with 3.7% para-formaldehyde (PFA) for 10 min at RT
and permeabilized with ice-cold methanol for 10 min. WPBs were
visualized using the anti-VWF mouse monoclonal antibody CLB-
RAg20 (subclass IgG2b) and Alexa 568-conjugated goat anti-
mouse IgG2b. The cellular membrane was stained with rabbit
polyclonal anti-b-catenin antibody and Alexa 633-conjugated goat
anti-rabbit antibody. The MTOC was visualized using the mouse
IgG1 monoclonal antibody anti-c-tubulin and Alexa 488-conju-
gated goat anti-mouse IgG1. KLF2 was visualized using the rabbit
polyclonal antibody anti-KLF2 and Alexa 488-conjugated goat
anti-rabbit IgG. Mouse IgG2a CLB-HEC75 directed against
CD31 and Alexa 633-conjugated goat anti-mouse IgG2a were
used in combination with the KLF2 antibody. Stainings were
performed in PBS supplemented with 1% human albumin and
0.02% saponin. Cells were embedded in Vectashield and analyzed
by confocal microscopy using a Zeiss LSM510 (Carl Zeiss,
Sliedrecht, the Netherlands) equipped with the appropriate filters.
Three-dimensional images were generated by making optical
sections of 0.25 mm along the Z-axis of the cells (Z-stacks).
Quantification of WPB Clustering
Image restoration and 3D analysis of z-stacks of single cells was
performed using Image Pro Plus 6.1 (Media Cybernetics, Breda,
the Netherlands). Staining for CD31 was used to select an area of
interest encompassing a single cell. The location of the MTOC
was determined by staining for c-tubulin. The 3D Open filter was
applied to separate narrowly connected WPBs. 3D data were
rendered to a 3D Gaussian surface using the 3D constructor
module to automatically recognize vesicles and the MTOC and to
calculate their position. The distance of the individual WPBs to the
MTOC was calculated using the following formula: d = !((xWPB-
xMTOC)
2+ (yWPB – yMTOC)2+ (zWPB – zMTOC)2), where x, y and z
are the spacial coordinates in the 3D model (respectively the
width, height and depth).
Statistics
Differences in WPB length, amount and number of clustered
WPBs were analyzed using a Student’s t-test or two-way ANOVA
with significance assumed at p,0.05.
Results
Expression of KLF2 Results in More but Shorter WPBs
Lentiviral transduction was used to introduce KLF2 into
BOECs. Early passage BOECs were transduced with lentivirus
containing KLF2 cDNA or empty virus (mock). Cells were
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cultured for 7 days to allow for the establishment of a steady-state
gene expression pattern, as KLF2 effects are induced only after
prolonged overexpression (more than 24 hours) [6]. An increased
expression of KLF2 in KLF2-transduced cells compared to mock-
transduced cells was demonstrated by immunocytochemistry
(Figure 1A) and by Western blot analysis (Figure 1B).
It has been reported previously that expression of KLF2
increases the secretion of VWF and the average amount of WPBs/
cell in HUVECs [3]. Expression of KLF2 in BOECs also resulted
in a 4-fold increase in the number of WPBs per cell (Figure 2B).
Following stimulation with cAMP raising agonists the average
number of WPBs per cell declined 2-fold in both KLF2- and
mock-transduced endothelial cells (Figure 2B). Close inspection of
the morphology of WPBs in KLF2-transduced cells revealed a
slightly altered morphology. The average length of WPBs in KLF2
lentiviral transduced BOECs was 1.360.3 mm whereas WPB in
mock-transduced BOECs had an average length of 1.7 mm
(Figures 2A and C). Less elongated WPBs were frequently
observed in KLF2-expressing cells, however most WPBs, although
shorter, remained rod-shaped. The forskolin- and epinephrine-
stimulated secretion of VWF in the medium of mock- and KLF2-
transduced BOECs was determined (Figure 2D). A 2-fold increase
in stimulated VWF release in KLF2-transduced cells was
observed. Also, an increase in VWF release in the absence of
secretagogues was observed in KLF2 expressing cells although the
extent of this increased release varied between 0.1 to 0.6 nM
among different experiments.
WPBs Lack Angiopoietin-2 after Expression of KLF2
The mRNA expression of the proinflammatory protein
angiopoietin-2 has previously been shown to be decreased in
endothelial cells expressing KLF2 [4]. This prompted us to
determine whether Ang2 was present in WPBs of endothelial cells
expressing KLF2. First, we addressed the intracellular distribution
of Ang2 in mock-transduced endothelial cells. In agreement with
previous observations [17] we identified Ang2 in WPBs
(Figure 3A). Approximately 20–50% of individual cells displayed
Ang2 staining in WPBs. Within a single cell on average 40% of the
WPBs stained positive for Ang2. In contrast to previous
observations we observed that Ang2 and P-selectin were co-stored
in WPBs suggesting that these proteins are not stored in these
organelles in a mutually exclusive manner (Figure 3A) [17]. We
next addressed Ang2 storage in KLF2-transduced BOEC. In the
majority of KLF2-transduced cells, no Ang2 staining was observed
(Figure 3C). The decrease in Ang2 expression in KLF2 expressing
cells was verified by western blot (Figure 3B). To confirm these
findings we performed stimulation experiments using KLF2- and
mock-transduced endothelial cells. A two fold increase in secreted
Ang2 was observed following stimulation of mock-transduced cells
with phorbol 12-myristate 13-acetate (PMA). Conversely, no
regulated release of Ang2 was observed in KLF2-transduced
endothelial cells (Figure 3E, F). These findings show that
expression of KLF2 diminishes the Ang2-content of WPBs. We
also monitored the presence of other WPB-components in KLF2-
transduced endothelial cells. Osteoprotegerin (OPG) staining was
observed in WPBs of both KLF2 and mock-transduced endothelial
cells by immunofluorescence staining (Figure 4A). Western blot
analysis revealed that OPG protein levels were not affected by
KLF2 expression (Figure 4B). A reduced staining was observed for
P-selectin but the effect of KLF2 was less pronounced when
compared to Ang2 (data not shown). KLF2 has been reported to
downregulate IL-1ß-induced upregulation of IL-6 and IL-8
expression. Inspection of IL-1ß treated mock- and KLF2-
transduced cells did not reveal major changes in the IL-6 and
IL-8 distribution as assessed by confocal microscopy (Figure 5A
and C). Western blot analysis of IL-8 and IL-6 however, revealed a
slight decrease in expression levels of both proteins upon
expression of KLF2 (Figure 5B). To quantitatively address this
issue we determined IL-8 and IL-6 release following agonist-
induced WPB release. Upon stimulation with PMA a significant
reduction in the amount IL-8 was observed in KLF2-transduced
cells when compared to mock-transduced cells (Figure 5E). A
slightly reduced basal release of IL-6 was observed in KLF2-
transduced cells, however, the amount of PMA induced release of
IL-6 was similar in KLF2-transduced and mock-transduced cells
(Figure 5F). Together our findings show that IL-8 and Ang2
content of WPBs is reduced in endothelial cells expressing KLF2.
cAMP-mediated Clustering of WPBs is Reduced in KLF2
Expressing BOECs
Previously, we have shown that WPBs cluster at the MTOC in
response to stimulation with cAMP-raising agonists [23,24]. While
performing our initial characterization of KLF2 expressing
BOECs we noted a striking absence of clustered WPBs following
stimulation with forskolin or epinephrine. This prompted us to
investigate a possible role for KLF2 in regulation of clustering by
performing a quantitative analysis of WPB clustering in both
KLF2- and mock-transduced BOECs. KLF2- or mock-transduced
BOECs were stimulated for 1 hour with forskolin and IBMX,
epinephrine and IBMX or serum free medium alone as a control.
After stimulation, cells were stained for VWF, c-tubulin and b-
catenin. Cells were randomly chosen and analyzed. A ‘clustering’
Figure 1. Expression of KLF2 in BOECs. (A) Immunofluorescent analysis of mock- and KLF2-transduced BOECs. Cells were immunostained for
CD31 (red) and KLF2 (green); nuclei were stained using DAPI (blue). Scale bars: 20 mm; (B) Western blot analysis of KLF2 expression in lysates of KLF2-
transduced and mock-transduced BOECs; a-tubulin is shown as a loading control.
doi:10.1371/journal.pone.0038399.g001
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circular region was defined around the MTOC, wherein WPBs
were considered to be clustered. The limit of this region was set at
a radius of 6 mm, which is the average length of two longitudinally
arranged WPBs (Figure 6A). In mock-transduced BOECs the
majority of WPBs were found near the MTOC in response to
forskolin and epinephrine stimulation. WPB clustering was
respectively 78% and 66% for these two agonists (Figures 6B
and C). In unstimulated BOECs the perinuclear WPB clustering
was about 21% (Figure 6C). A clear reduction in WPB clustering
was observed in BOECs expressing KLF2, where the average
percentage of WPB clustering after forskolin and epinephrine
stimulation was 24% and 33% respectively (Figures 6B and C).
Furthermore, a reduction in the percentage of perinuclear WPB in
unstimulated KLF2 cells was observed compared to mock-
transduced cells (Figure 6C). The distance of individual WPBs to
the MTOC in KLF2- and mock-transduced cells was determined.
This analysis revealed that the average distance of WPBs from the
MTOC is larger in KLF2-transduced cells when compared to
mock-transduced endothelial cells following stimulation with
cAMP raising agonists (Figure 6D–F). Together these findings
show that perinuclear clustering of WPBs is reduced in KLF2
expressing endothelial cells.
Discussion
KLF2 is responsible for the shear stress induced modulation
of gene expression that limits inflammatory responses and
thereby sustains endothelial quiescence [3,4,30]. In this study we
explored the effects of KLF2 on the dynamics and properties of
Figure 2. Reduced average length of WPBs in KLF2-transduced BOECs. (A) Confocal microscopy analysis of WPBs in mock- and KLF2-
transduced BOECs stained for VWF (red) and DAPI (blue). Scale bars: 10 mm. (B) Average amount of WPBs per cell in unstimulated and stimulated
mock-transduced BOECs and KLF2-transduced BOECs. ***P,0.0001 using Student’s t- test (C) The average length of the WPBs in individual mock- or
KLF2-transduced BOECs. WPBs from 20 randomly selected cells were analyzed. ***P,0.0005 by Student’s t-test (D) Release of VWF from forskolin/
IBMX- and epinephrine/IBMX-stimulated KLF2 (black bars)- and mock (white bars)-transduced BOECs. ***P,0.0001 by Students t-test. Error bars
represent SEM.
doi:10.1371/journal.pone.0038399.g002
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WPBs. Lentiviral over-expression results in a 20-fold increase of
KLF2 as determined by RT-PCR [3]. In comparison, HUVECs
grown under laminar flow for 8 hours at a flow rate of
12 dyne/cm2, showed a 12-fold increase in KLF2 levels [31]. In
vivo KLF2 protein levels have been determined in swine
endothelium of the atherosusceptible aortic arch (AA) and the
atheroresistant descending thoracic aorta (DT); a 1.5-fold
increase in KLF2 protein levels were found in the DT as
compared to the AA [32]. However, it was reported that
pathological hepatic hemodynamic variations occurring during
Figure 3. Angiopoietin-2 content of WPBs in mock- and KLF2-transduced BOECs. (A) Immunofluorescence image showing the co-
localization of Ang2 (green) and P-selectin (red) in WPBs of mock-transduced BOECs. Nuclei were visualized with DAPI (blue). Scale bars: 10 mm. (B)
Western blot analysis of VWF, KLF2 and Ang2 expression in lysates of mock- and KLF2-transduced BOECs; a-tubulin is shown as a loading control. (C)
Mock- and KLF2-transduced BOECs stained for VWF (red) and Ang2 (green). Nuclei were stained using DAPI (blue). Scale bars: 10 mm. (D-E) Release of
Ang2 and VWF from PMA-stimulated KLF2 (black bars)- and mock (white bars)-transduced BOECs measured by determining the concentration of
Ang2 in the medium by ELISA. **P,0.001; ***P,0.0001 by Students t-test. (F) Time course of regulated VWF and Ang2 secretion after PMA
stimulation of mock- and KLF2-transduced BOECs.
doi:10.1371/journal.pone.0038399.g003
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liver cirrhosis development caused a 6-fold increase of KLF2
protein levels in vivo [33].
In agreement with previous observations we show that the
number of secretable WPBs increases upon expression of KLF2
[3]. We anticipate that the increased number of WPBs results from
the upregulation of VWF mRNA levels induced by KLF2 [3]. The
increase in number of WPBs in KLF2-transduced cells suggests
that generation of WPBs is mainly driven by the amount of VWF
synthesized by endothelial cells. It has been well-established that
the formation of WPBs is strictly dependent on the presence of
VWF [34]. Absence of WPBs affects the regulated release of other
WPB constituents such as P-selectin. An elegant study revealed
that the absence of releasable P-selectin in VWF deficient mice
impairs leukocyte recruitment [35]. Based on these findings we
anticipate that increased numbers of WPBs in KLF2-transduced
cells can potentially enhance the storage capacity of other WPB
components. We observed that the average WPB length in KLF2-
transduced cells is consistently reduced by 0.4 mm when compared
to mock-tranduced cells (Figure 2). Biogenesis and elongation of
WPBs is mediated by a clathrin/AP-1 coat that transiently
associates with newly forming WPB in the TGN [36]. We
speculate that expression of KLF2 modulates the function or
expression of these proteins thereby limiting the elongation of
newly forming WPBs. The overall multimeric composition of
secreted VWF in medium of KLF2- and mock-transfected BOECs
was similar, suggesting that the observed decrease in WPB length
is not due to a change in multimerization of VWF. (Figure S1).
However, our analysis did not allow us to assess whether the
maximum size of VWF multimers is affected by the expression of
KLF2.
Upon stimulation of endothelial cells with cAMP-raising
agonists a significant number of WPBs escape from their release
and are transported to the MTOC [23]. Here, we show that
clustering of WPBs at the MTOC is impaired in KLF2 expressing
endothelial cells (Figure 6). Clustering of WPBs is dependent on
dynein-mediated transport along microtubules [24]. When lami-
nar fluid shear stress is applied microtubules align in the direction
of the flow and the MTOC migrates downstream of the nucleus
[37]. Expression of KLF2 does not result in major changes in the
properties of microtubules nevertheless clustering of WPBs is
impaired in these cells. Despite the absence of clustering at the
MTOC a considerable number of WPBs is retained inside the
KLF2 expressing cells that have been triggered by cAMP-raising
agonists (Figure 2). We speculate that defects in minus end directed
transport of WPBs along microtubules prevent perinuclear
transport under these conditions. It has been found previously
that the retrograde transport of WPBs is mediated by the dynein-
dynactin complex and that protein kinase A (PKA) is involved in
this process, as inhibition of PKA prevents clustering of WPBs at
the MTOC. It is unlikely that KLF2 targets activation of PKA as it
has been described previously that the sensitivity of KLF2
expressing endothelial cells for cAMP-raising agonists like
epinephrine and forskolin is not reduced [3]. We speculate that
KLF2 modulates PKA-mediated phosphorylation of motor
protein complexes regulating retrograde transport of WPBs. We
previously proposed that clustering of WPBs at the MTOC might
be a mechanism to secure vascular homeostasis by preventing
release of pro-inflammatory contents from WPBs [24].
Previously, it was reported that the storage of Ang2 and P-
selectin in WPBs was mutually exclusive [17]. In this study, we
have shown that Ang2 and P-selectin co-localize in WPBs. P-
selectin is able to bind to the D’D3 domain of VWF [38] via its
luminal domain, however it was also reported that a targeting
motif in the cytoplasmic domain of P-selectin was sufficient for
sorting of P-selectin to WPBs [39]. This makes mutual exclusion
by competitive binding of P-selectin and Ang2 to VWF unlikely.
KLF2 is known to cause downregulation of expression of pro-
inflammatory cytokines, some of which can be present in the
WPBs [3,40]. This is supported by the finding that the amount of
Ang2 and (to a lesser extent) IL-8 in the WPBs is reduced in KLF2
expressing endothelial cells (Figure 3 and 5). While angiopoietin-1
(Ang1)/Tie-2 signaling promotes vascular quiescence, the pro-
inflammatory protein Ang2 destabilizes the vasculature at sites of
vessel remodeling by antagonizing the binding of Ang1 to Tie-2
Figure 4. OPG content of mock- or KLF2-transduced BOECs. (A) Immunofluorescence image showing co-localization of OPG (green) and VWF
(red) in both mock- and KLF2-tranduced BOECs. Nuclei were stained using DAPI (blue). Scale bars: 10 mm.(B) Western blot analysis for VWF, KLF2, IL-8
and IL-6 expression in lysates of mock- and KLF2-transduced BOECs; a-tubulin was shown as a loading control.
doi:10.1371/journal.pone.0038399.g004
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[41]. Ang2 primes the endothelium to respond to pro-inflamma-
tory cytokines, such as VEGF, TNF-a and IL-1b [42]. In this
manner Ang2 triggers an inflammatory response by activating the
endothelium, inducing endothelial permeability and extravasation
of inflammatory cells [43] and thereby contributes to premature
atherosclerosis. A three- to four-fold decline in Ang2 levels induced
Figure 5. IL-6 and IL-8 content of KLF2-transduced BOECs. (A) Immunofluorescence image showing co-localization of IL-6 (green) and VWF
(red) in IL-1b-treated KLF2- and mock-transduced BOECs. Nuclei were visualized with DAPI (blue). Scale bars: 10 mm. (B) Western blot analysis for VWF,
KLF2, IL-8 and IL-6 expression in lysates of mock- and KLF2-transduced BOECs; a-tubulin was shown as a loading control. (C) Immunofluorescence
image showing co-localization of IL-8 (green) and VWF (red) in IL-1b-treated KLF2- and mock-transduced BOECs. Nuclei were visualized with DAPI
(blue). Scale bars: 10 mm. (D) Release of VWF from PMA-stimulated KLF2 (black bars)- and mock (white bars)-transduced cells (IL-1b-treated),
measured by determining the concentration of VWF in the conditioned medium by ELISA. **P,0.001; ***P,0.0001 by Students t-test (E-F) Release of
IL-6 and IL-8 from PMA-stimulated KLF2 (black bars)- and mock (white bars)-transduced cells (IL-1b-treated), measured by determining the
concentration of IL-6 and IL-8 in the conditioned medium by ELISA. The amount of IL-6 released without stimulation was slightly reduced in KLF2
expressing cells when compared to mock-transduced cells. NS: non-significant; *P,0.01; ***P,0.0001 by Students t-test.
doi:10.1371/journal.pone.0038399.g005
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by flow (30 dyne/cm2) has been reported [44]. The observed
decline in Ang2 levels in KLF2-transduced endothelial cells is
consistent with this observation. Our findings show that KLF2-
transduced cells do not contain a rapidly releasable reservoir of
Ang2. Recently, VWF has also been implicated in the regulation
of angiogenesis [45]. Absence of VWF resulted in a two-fold
release in Ang2 levels in culture supernatants [45]. As Ang2 is co-
stored with VWF in WPBs; in the absence of VWF Ang2 is
released in a constitutive manner. We anticipate that targeting of
Ang2 to WPBs provides a mechanism to reduce circulating levels
of Ang2 thereby promoting vascular quiescence. In the absence of
WPBs, due to lack of VWF, Ang2 levels increase and destabilize
the vasculature allowing for vascular remodeling [41].
Reduced expression of Ang2 by endothelial cells, decreases
inflammation and vascular remodeling by making the endotheli-
um less responsive to pro-inflammatory cytokines. The decrease in
Figure 6. Effects of KLF2 expression on WPB clustering. (A) 3D model of WPB distribution (generated by Image Pro Plus) displaying non-
clustered WPBs dispersed through the cell (left panel) and clustered WPB in cells treated with forskolin and IBMX (right panel). A circle with a radius of
6 mm around the MTOC, detected with anti-c-tubulin antibodies, was used to calculate the percentage of clustered WPBs. (B). Mock- or KLF2-
transduced BOECs were stimulated with forskolin + IBMX or epinephrine + IBMX or serum free medium (unstimulated). Following stimulation cells
were stained for b-catenin (red), VWF (green) and c-tubulin (white). The location of the MTOC is indicated by an arrow. Representative confocal
images are shown as total intensity projections of the various optical sections acquired per sample (XYZ projections). Scale bars: 10 mm. (C) Mock- or
KLF2-transduced BOECs were stimulated with forskolin + IBMX or epinephrine + IBMX or serum free medium (unstimulated) were analyzed for WPB
clustering as described in Figure 6A. ***P,0.001 using two-way ANOVA (D-F) Quantification of relative numbers of WPBs and their distance to the
MTOC in non-stimulated and stimulated KLF2- and mock-transduced cells. Error bars represent SEM.
doi:10.1371/journal.pone.0038399.g006
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secreted IL-8 from IL-1b stimulated KLF2 cells might result from
this decreased sensitivity to cytokines; however the amount of
secreted IL-6 is still the same in KLF2 cells. These findings suggest
that KLF2 expressing endothelial cells are less prone to vascular
remodeling, inflammation and ultimately atherosclerosis. In
contrast, at sites of disturbed flow, where endothelial cells do not
express KLF2, Ang2 can be released from the WPBs, promoting
inflammation and vascular remodeling and therefore making these
sites more susceptible to premature atherosclerosis and plaque
neovascularization. Our findings on the lack of Ang2 in KLF2-
transduced endothelial cells together with previous observation on
down-regulation of Ang2 levels by flow provide a mechanism to
stabilize newly formed vasculature by reducing the synthesis of
vessel-destabilizing Ang2.
Supporting Information
Figure S1 VWF multimer gel. Secreted VWF in medium
of PMA-induced mock- and KLF2-transduced BOECs.
The multimerization patterns of mock and KLF2 samples appear
to be similar.
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